CCM
HZNP

Chicago Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Chicago Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-81,114
Closed -$11.5M – 39
2023
Q3 		$11.5M Buy
81,114
+2,584
+3% +$278K 30.31% 1
2023
Q2 		$8.08M Sell
78,530
-47,500
-38% -$5.01M 10.35% 4
2023
Q1 		$13.8M Buy
126,030
+86,209
+216% +$9.53M 15.1% 2
2022
Q4 		$4.53M Buy
+39,821
New +$3.31M 4.11% 10

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Chicago Capital Management's HZNP Position: Q4 2023 in Review

Chicago Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 81,114 shares — an estimated $11.5M sold.

Chicago Capital Management first reported a position in HZNP in Q4 2022 and held it in 4 quarters. The position peaked at $13.8M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Chicago Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Chicago Capital Management sold 81,114 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $11.5M.
  • Chicago Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 4 quarters.
  • Chicago Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $13.8M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Chicago Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.